Company Encyclopedia
View More
name
Nus Esg S-Cp Grw
NUSC.US
News
View More

Carpenter Technology Corporation (NYSE:CRS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Carpenter Technology Corporation (NYSE:CRS) has received a "Moderate Buy" consensus from eleven ratings firms, with two hold and nine buy ratings. The average 12-month price target is $371.14. Recent insider sales include COO Brian J. Malloy and VP Elizabeth A. Socci. Institutional investors like Russell Investments and Wellington Management have increased their stakes. The stock opened at $321.03, with a market cap of $15.99 billion and a P/E ratio of 39.25.

Market Beat·
US
CRS
+0.47%
Market Beat·
US
CRS
+0.47%

Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference | MRNA Stock News

Moderna, Inc. announced it will present at the 44th J.P. Morgan Healthcare Conference on January 12th. The presentation will be webcast live and archived for 30 days on Moderna's website. Moderna is a leader in mRNA medicine, focusing on vaccines and therapeutics for various diseases. For more details, visit modernatx.com.

StockTitan·
US
MRNA
+3.88%
StockTitan·
US
MRNA
+3.88%

TechnipFMC PLC Stock Underperforms Tuesday When Compared To Competitors

TechnipFMC PLC's stock fell 5.15% to $43.82 on Tuesday, marking its third consecutive day of losses. The stock underperformed compared to competitors like Oil States International Inc., which fell 3.42%. Trading volume was higher than the 50-day average. The stock is 7.42% below its 52-week high of $47.33.

Dow Jones·
US
FTI
+0.55%
Dow Jones·
US
FTI
+0.55%

Oil Falls To $55 And Energy Stocks Suffer Worst Day Since April

Oil prices fell to $55 amid hopes for a Russia-Ukraine peace deal, leading to a significant drop in energy stocks. West Texas Intermediate crude fell 2.6%, marking its fourth consecutive decline. Energy stocks, including Phillips 66 and TechnipFMC, suffered their worst day since April, with the Energy Select Sector SPDR Fund dropping 2.9%. The decline was driven by optimism for a ceasefire and potential easing of sanctions on Russian energy exports, alongside concerns over abundant supply and weakening demand.

benzinga_article·
US
FTI
+0.55%
US
PSX
-0.43%
benzinga_article·
US
FTI
+0.55%
US
PSX
-0.43%

Moderna Options Trading: A Deep Dive into Market Sentiment

Deep-pocketed investors are showing a bullish sentiment towards Moderna (NASDAQ:MRNA), with significant options trading activity detected. Benzinga's options scanner highlighted 10 extraordinary options activities, with 60% bullish and 30% bearish. The price range targeted is $22.0 to $39.0. Moderna's stock is up 0.81% at $29.7. Analysts have mixed ratings, with price targets ranging from $18 to $63. Moderna, a biotech firm, has 35 mRNA development candidates in clinical studies. Next earnings are expected in 60 days.

benzinga_article·
US
MRNA
+3.88%
benzinga_article·
US
MRNA
+3.88%
© 2025 Longbridge｜Disclaimer